FDA Approves Tezspire (tezepelumab-ekko) for Chronic Rhinosinusitis with Nasal Polyps

Oct 19, 2025 - 21:00
 0  1
THOUSAND OAKS, Calif., Oct. 17, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved Tezspire (tezepelumab-ekko) for the add-on maintenance treatment of inadequately...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0